1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus JANUARY 2016

Autoimmune Drug Focus JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - IBD Research Set To Benefit From Synchronicity In 2016
Industry Trend Analysis - Afrezza Agreement Termination An Opportunity Rather Than An Obstacle
Industry Brief - FDA Approves Humulin R U-500 KwikPen
Industry Brief - Novo Nordisk Launches Tresiba In US
Industry Brief - Gilead Terminates Simtuzumab Phase II Study In IPF
Industry Brief - Data From Biosimilar Infliximab Study Presented
Industry Brief - Enrolment Begins In Phase II Trial Of Cytori Cell Therapy In CD
Industry Brief - GeNeuro Initiates GNbAC1 Phase IIb Trial In RRMS
Industry Trend Analysis - Laquinimod Viability In Doubt
Industry Brief - EMD Serono Takes Exclusive Promotion Of Rebif In US
Industry Brief - Can-Fite Submits CF101 Phase III Protocol To IRB In RA
Industry Brief - FDA Accepts Sarilumab BLA For Review
Industry Brief - AbbVie Initiates Phase III Trial Programme Of ABT-494 In RA
Industry Brief - Sorrento Biosimilars Show Positive Phase III Results
Industry Brief - Health Canada Approves Stelara For Moderate-To-Severe Psoriasis In Adolescents
Industry Brief - Torrent Launches Adalimumab Biosimilar
Industry Trend Analysis - Marketing Will Be Key To Creating A Viable Biosimilar Etanercept Niche
Industry Brief - Milestone Triggered As Lilly Submits Baricitinib NDA To FDA For RA
Company Brief - Positive Phase III Results Reported For CHS-0214
Industry Brief - FDA Accepts Amgen's Biosimilar Adalimumab For Review
Industry Brief - FDA Approves Consentyx For AS/PsA
Industry Brief - FDA Accepts Brodalumab BLA For Review In Plaque Psoriasis
Industry Brief - Neovacs Secures Funds To Support Development Of IFN Kinoid
Industry Brief - FTC Clears Galapagos/Gilead Filgotinib Partnership
Industry Brief - Galapagos/Gilead Complete Closing Of Filgotinib Collaboration
Industry Brief - Stellar/Neovacs Form JV To Produce Conjugated Therapeutic Vaccines
Industry Brief - Autoimmune Conferences - April 2016

Table Of Contents

Autoimmune Drug Focus JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Laboratory Products Purchasing Trends, 2016–2017

Global Laboratory Products Purchasing Trends, 2016–2017

  • $ 6000
  • Industry report
  • December 2016
  • by Frost & Sullivan

An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. ...

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.